Snowball logo
logo
ITCI

Intra-Cellular Therapies, Inc

-- $0,00 $  (0%)
Оценка
EPS
-0,73
Рост
Выручка, YoY
51,49%
Чистый доход, YoY
40,92%
FCF, YoY
-513,53%
Прогноз
EPS (FWD)
3,126
Другое
Размер лота
1 шт.
О компании
Тикер
ITCI
ISIN
US46116X1019
Страна
США
Сектор (GICS)
Здравоохранение
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and neurological disorders. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It distributes its products through third-party wholesale drug distributors. The company was founded in 2002 and is based in Bedminster, New Jersey. As of April 2, 2025, Intra-Cellular Therapies, Inc. operates as a subsidiary of Johnson & Johnson Innovative Medicine.

Часто задаваемые вопросы

В каком секторе работает Intra-Cellular Therapies, Inc (ITCI)?

Intra-Cellular Therapies, Inc относится к сектору Здравоохранение.

Выплачивает ли Intra-Cellular Therapies, Inc (ITCI) дивиденды?

Нет, Intra-Cellular Therapies, Inc не выплачивает дивиденды.